LEIDEN, Netherlands & CAMBRIDGE, Mass., April 02, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for
… to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today … followed by a live Q&A session. Session: Stem cells/gene therapy/transplantation Date: May 6, 2021 at 5:15pm EDT …
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 25, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced that Company management will pres
… to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today … retinal degenerations, autoimmune retinopathy, and gene therapy associated uveitis. He is a principal investigator …
… to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare … lead to blindness in early childhood. No form of therapy is currently available,” said Dr. Katarina Stingl of … Tübingen, Investigator in the ILLUMINATE trial. “ProQR’s RNAtherapy for the p.Cys998X mutation showed the potential …